Loading clinical trials...
Loading clinical trials...
Safety and Immunogenicity of Shingrix in Renal Transplant Recipients
Conditions
Interventions
Shingrix
Locations
4
United States
University of Colorado Anschutz
Aurora, Colorado, United States
Emory University
Atlanta, Georgia, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Baylor College of Medicine
Houston, Texas, United States
Start Date
March 2, 2023
Primary Completion Date
June 1, 2029
Completion Date
June 1, 2029
Last Updated
April 8, 2026
NCT06056102
NCT06343727
NCT06972069
NCT05283512
NCT06314503
NCT03573089
Lead Sponsor
University of Colorado, Denver
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions